Skip to main content
SpringerLink
Log in

Neuroimaging and Clinical Trials

Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop

  • News and Commentary
  • Published:
Molecular Psychiatry Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kohannim O et al. Neurobiol Aging 2010; 31: 1429–1442.

    Article  Google Scholar 

  2. Holland D et al. Proc Natl Acad Sci U S A 2009; 106: 20954–20959.

    Article  CAS  Google Scholar 

  3. Stein JL et al. Neuroimage 2010; 53: 1160–1174.

    Article  CAS  Google Scholar 

  4. Paulus MP, Stein MB . Neuropsychol Rev 2007; 17: 179–188.

    Article  Google Scholar 

  5. Furmark T et al. J Neurosci 2008; 28: 13066–13074.

    Article  CAS  Google Scholar 

  6. Jack CR et al. Lancet Neurol 2010; 9: 119–128.

    Article  CAS  Google Scholar 

  7. Brennan BP et al. Neuropsychopharmacology 2010; 35: 834–846.

    Article  CAS  Google Scholar 

  8. Bullmore E, Sporns O . Nat Rev Neurosci 2009; 10: 186–198.

    Article  CAS  Google Scholar 

  9. Thomas AG et al. Neuroimage 2009; 48: 117–125.

    Article  Google Scholar 

  10. Fox NC et al. Neurology 2005; 64: 1563–1572.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Special thanks to Dr Kiran Deol for her marvelous behind the scenes work organizing the workshop, as well as Marc, Patricia and all the staff of the Domaine des Escaunes who made our time so enjoyable. We also extend our gratitude to Dr Melissa Green for her initial work in creating and promoting the workshop, as well as Katherine Koulizakis for her administrative support. Finally, we thank our various drivers for their peerless knowledge of the Provencal countryside.

Author information

Author notes

  1. Department of Psychiatry and Clinical Psychobiology, Faculty of Medicine, University of Barcelona and Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain

  2. School of Engineering Science, Simon Fraser University, Burnaby, BC, Canada

  3. Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, VIC, Australia

  4. Neuronal Targets DPU, GlaxoSmithKline, Philadelphia, PA, USA

  5. Department of Psychiatry & Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK

  6. McLean Hospital, Belmont, MA, USA and Harvard Medical School, Boston, MA, USA

  7. Laboratory of Neuro Imaging, UCLA School of Medicine, Los Angeles, CA, USA

Authors and Affiliations

  1. Regenerative Neuroscience Group, Faculty of Medicine, Neuropsychiatric Institute, Prince of Wales Hospital, Randwick, Sydney, 2031, NSW, Australia

    M Valenzuela, D Bartrés-Faz, F Beg, A Fornito, E Merlo-Pich, U Müller, D Öngür, A W Toga & M Yücel

  2. Brain and Ageing Research Program, School of Psychiatry, University of New South Wales, Australia

    M Valenzuela, D Bartrés-Faz, F Beg, A Fornito, E Merlo-Pich, U Müller, D Öngür, A W Toga & M Yücel

Authors
  1. M Valenzuela
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Bartrés-Faz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F Beg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Fornito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Merlo-Pich
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D Öngür
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A W Toga
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Yücel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Valenzuela.

Ethics declarations

Competing interests

EM-P is an employee of GlaxoSmithKline.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valenzuela, M., Bartrés-Faz, D., Beg, F. et al. Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop. Mol Psychiatry 16, 1064–1066 (2011). https://doi.org/10.1038/mp.2011.62

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2011.62

  • Springer Nature Limited

This article is cited by

Search

Navigation